In a recent development, the U.S has called upon the Eighth Circuit to disapprove a transfer pricing method used by the U.S. Tax Court. The method questioned is one used in a decision that found Medtronic Inc., a prominent medical device company, having reported its income less than actual. The U.S. argues that the methodology in question not only contradicts Treasury regulations, but also fails to accurately assess the income of the company.
Medtronic Inc. has attracted attention owing to the conclusion that it underreported its income. While the exact discrepancies and specifics are a subject of ongoing discussions, the U.S. alleges an infringement of Treasury regulations by the approach of the U.S. Tax Court in assessing income. Further details on this particular approach and its potential contradiction to regulations, however, are still not very clear.
This development highlights the critical, yet complex nature of transfer pricing methods. The outcome of Eighth Circuit’s reaction could potentially shape future applications and determinations of such methodologies in the realm of tax law.
For more detailed insights into this matter, visit the initial coverage of this story on Law360.